Founder of Amplexd Therapeutics
Amplexd Therapeutics
The startup develops non-invasive therapeutics for early cervical cancer, utilizing targeted treatments for low-grade dysplasia and alternatives to invasive surgeries for high-grade dysplasia. This approach provides affordable healthcare solutions to combat the public health crisis posed by human papillomavirus-related cervical cancer.
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops non-invasive therapeutics for early cervical cancer, utilizing targeted treatments for low-grade dysplasia and alternatives to invasive surgeries for high-grade dysplasia. This approach provides affordable healthcare solutions to combat the public health crisis posed by human papillomavirus-related cervical cancer.